1. Home
  2. TNFA vs SNAX Comparison

TNFA vs SNAX Comparison

Compare TNFA & SNAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • SNAX
  • Stock Information
  • Founded
  • TNFA 2014
  • SNAX 2017
  • Country
  • TNFA United States
  • SNAX United States
  • Employees
  • TNFA N/A
  • SNAX N/A
  • Industry
  • TNFA
  • SNAX Packaged Foods
  • Sector
  • TNFA
  • SNAX Consumer Staples
  • Exchange
  • TNFA NYSE
  • SNAX Nasdaq
  • Market Cap
  • TNFA 3.7M
  • SNAX 3.5M
  • IPO Year
  • TNFA N/A
  • SNAX N/A
  • Fundamental
  • Price
  • TNFA $1.20
  • SNAX $0.93
  • Analyst Decision
  • TNFA
  • SNAX
  • Analyst Count
  • TNFA 0
  • SNAX 0
  • Target Price
  • TNFA N/A
  • SNAX N/A
  • AVG Volume (30 Days)
  • TNFA 27.7K
  • SNAX 266.6K
  • Earning Date
  • TNFA 11-29-2024
  • SNAX 11-13-2024
  • Dividend Yield
  • TNFA N/A
  • SNAX N/A
  • EPS Growth
  • TNFA N/A
  • SNAX N/A
  • EPS
  • TNFA N/A
  • SNAX N/A
  • Revenue
  • TNFA N/A
  • SNAX $19,364,444.00
  • Revenue This Year
  • TNFA N/A
  • SNAX $38.33
  • Revenue Next Year
  • TNFA N/A
  • SNAX N/A
  • P/E Ratio
  • TNFA N/A
  • SNAX N/A
  • Revenue Growth
  • TNFA N/A
  • SNAX N/A
  • 52 Week Low
  • TNFA $1.15
  • SNAX $0.75
  • 52 Week High
  • TNFA $10.68
  • SNAX $3.45
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 36.11
  • SNAX 46.55
  • Support Level
  • TNFA $1.26
  • SNAX $0.75
  • Resistance Level
  • TNFA $1.44
  • SNAX $0.96
  • Average True Range (ATR)
  • TNFA 0.13
  • SNAX 0.09
  • MACD
  • TNFA -0.02
  • SNAX 0.03
  • Stochastic Oscillator
  • TNFA 7.69
  • SNAX 57.87

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About SNAX Stryve Foods Inc.

Stryve Foods Inc is a healthy snacking company that manufactures, markets, and sells differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.

Share on Social Networks: